Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947771608> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2947771608 abstract "e12510 Background: Human epidermal growth factor receptor type 2 (HER2) is a significant driver of breast oncogenesis and has been found to be amplified in one-fifth of all breast cancers. Identification of cell surface over-expression of HER2 can be completed using immunohistochemistry (IHC), while amplification of the gene can be detected using fluorescence in situ hybridization (FISH) or differential polymerase chain reaction (PCR). Definitive diagnostic standards for each detection method are established, however approximately 5-10% of breast cancer patients have a HER2 status of “double equivocal,” offering little guidance to directing therapy. Previously, selected reaction monitoring mass spectrometry (SRM-MS) illustrated the dynamic range of HER2 positive protein expression by IHC or amplified FISH to have a threshold determination of 740amol.We hypothesized that this method could delineate which ‘double equivocal’ patients may indeed express enough HER2 to be candidates for targeted therapy. Methods: Overall, 76 invasive breast cancer samples identified as equivocal by IHC and FISH between 1/1/2010 and 12/31/2017 were evaluated. Typical demographic and clinicopathologic data were collected to include age, race, histology, size, hormone receptor status, treatments and outcomes. HER2 levels in each equivocal sample were quantitated using SRM-MS. Data were analyzed using Fisher’s t-tests, chi-square and ANOVA (p < 0.05). Results: Using the 740 amol/ng as the SRM-MS cut-off for HER2 positivity, the group was divided into two cohorts. No significant differences were found for demographic or pathologic variables. While identified HER2 levels were between 209.1-1286.6amol, 18 patients had SRM-MS results above the threshold but outcomes were not correlated with treatment received. Conclusions: We report the largest series of doubly equivocal HER2 patients evaluated with SRM-MS. For patients with invasive ductal carcinoma, SRM-MS was not able to identify patients for whom HER2 directed therapy would be a benefit. Future plans include an assessment of this cohort with an RNA seq algorithm given the high degree of accuracy we have shown with known HER2 positives and negatives." @default.
- W2947771608 created "2019-06-07" @default.
- W2947771608 creator A5000644777 @default.
- W2947771608 creator A5002766258 @default.
- W2947771608 creator A5006591586 @default.
- W2947771608 creator A5019666497 @default.
- W2947771608 creator A5025122002 @default.
- W2947771608 creator A5035010218 @default.
- W2947771608 creator A5065927929 @default.
- W2947771608 creator A5071240433 @default.
- W2947771608 creator A5073773875 @default.
- W2947771608 creator A5075181514 @default.
- W2947771608 creator A5077908907 @default.
- W2947771608 creator A5091310696 @default.
- W2947771608 date "2019-05-20" @default.
- W2947771608 modified "2023-09-24" @default.
- W2947771608 title "Selected reaction monitoring mass spectrometry (SRM-MS) evaluation of HER2 equivocal breast cancer." @default.
- W2947771608 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.e12510" @default.
- W2947771608 hasPublicationYear "2019" @default.
- W2947771608 type Work @default.
- W2947771608 sameAs 2947771608 @default.
- W2947771608 citedByCount "0" @default.
- W2947771608 crossrefType "journal-article" @default.
- W2947771608 hasAuthorship W2947771608A5000644777 @default.
- W2947771608 hasAuthorship W2947771608A5002766258 @default.
- W2947771608 hasAuthorship W2947771608A5006591586 @default.
- W2947771608 hasAuthorship W2947771608A5019666497 @default.
- W2947771608 hasAuthorship W2947771608A5025122002 @default.
- W2947771608 hasAuthorship W2947771608A5035010218 @default.
- W2947771608 hasAuthorship W2947771608A5065927929 @default.
- W2947771608 hasAuthorship W2947771608A5071240433 @default.
- W2947771608 hasAuthorship W2947771608A5073773875 @default.
- W2947771608 hasAuthorship W2947771608A5075181514 @default.
- W2947771608 hasAuthorship W2947771608A5077908907 @default.
- W2947771608 hasAuthorship W2947771608A5091310696 @default.
- W2947771608 hasConcept C121608353 @default.
- W2947771608 hasConcept C126322002 @default.
- W2947771608 hasConcept C143998085 @default.
- W2947771608 hasConcept C162356407 @default.
- W2947771608 hasConcept C185592680 @default.
- W2947771608 hasConcept C43617362 @default.
- W2947771608 hasConcept C530470458 @default.
- W2947771608 hasConcept C71924100 @default.
- W2947771608 hasConceptScore W2947771608C121608353 @default.
- W2947771608 hasConceptScore W2947771608C126322002 @default.
- W2947771608 hasConceptScore W2947771608C143998085 @default.
- W2947771608 hasConceptScore W2947771608C162356407 @default.
- W2947771608 hasConceptScore W2947771608C185592680 @default.
- W2947771608 hasConceptScore W2947771608C43617362 @default.
- W2947771608 hasConceptScore W2947771608C530470458 @default.
- W2947771608 hasConceptScore W2947771608C71924100 @default.
- W2947771608 hasLocation W29477716081 @default.
- W2947771608 hasOpenAccess W2947771608 @default.
- W2947771608 hasPrimaryLocation W29477716081 @default.
- W2947771608 hasRelatedWork W1001281783 @default.
- W2947771608 hasRelatedWork W101849968 @default.
- W2947771608 hasRelatedWork W1974681241 @default.
- W2947771608 hasRelatedWork W2003993482 @default.
- W2947771608 hasRelatedWork W2041675960 @default.
- W2947771608 hasRelatedWork W2056769186 @default.
- W2947771608 hasRelatedWork W2083934502 @default.
- W2947771608 hasRelatedWork W2091097671 @default.
- W2947771608 hasRelatedWork W2120719514 @default.
- W2947771608 hasRelatedWork W2128997791 @default.
- W2947771608 hasRelatedWork W2148591178 @default.
- W2947771608 hasRelatedWork W2415219532 @default.
- W2947771608 hasRelatedWork W2509264819 @default.
- W2947771608 hasRelatedWork W2739383471 @default.
- W2947771608 hasRelatedWork W2890520217 @default.
- W2947771608 hasRelatedWork W3038538767 @default.
- W2947771608 hasRelatedWork W2752077118 @default.
- W2947771608 hasRelatedWork W2837133507 @default.
- W2947771608 hasRelatedWork W2984046671 @default.
- W2947771608 hasRelatedWork W996209704 @default.
- W2947771608 isParatext "false" @default.
- W2947771608 isRetracted "false" @default.
- W2947771608 magId "2947771608" @default.
- W2947771608 workType "article" @default.